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INTRODUCTION
The goal of this Translational Research Partnership is to gather information on clinical outcomes and practices from several collaborating neurotrauma programs and synthesize this information to inform the development of relevant animal models of the dual diagnosis of Spinal Cord Injury (SCI) and Traumatic Brain Injury (TBI). These models will be used to identify improved therapeutic strategies that can be tested in the clinical setting. The process is meant to be iterative and interactive, producing a "community of practice and research."
The project links the Brain and Spinal Injury Center at the University of California, San Francisco (UCSF) with the Spinal Cord Injury and Brain Injury units at the Santa Clara Valley Medical Center (SCVMC) and the VA Palo Alto Health Care System (VAPAHCS).
In the first annual report, we reported that teleconferencing systems were established to facilitate communication among the study sites, and all Investigators participated in a series of meetings which rotated between participating medical centers to develop clinical database search strategies. These strategies allowed us to synthesize a dual diagnosis database, which we report in more detail below.
BODY
In the text below, we have taken the Statement of Work as a template and detailed how each task was completed and milestones accomplished.
Specific Aim 1: Develop community of practice and research and focus groups; and develop clinical database search strategy and dual diagnosis data
Task 1: Continue development of community of practice and research and focus groups 1a. All Investigators' meetings The Principal and Partnering Investigators have continued to meet to develop the community of practice and research linking the basic scientists working on animal models of brain and spinal cord injury with the clinical scientists working with patients having spinal cord injuries and traumatic brain injuries. During the second year of the project, this community has continued to develop and has grown to include several new members. Face-to-face meetings have been held at the VAPAHCS and UCSF as described below.
1b. Teleconference set up Telephone and internet-based audio conferencing has been set up to facilitate collaboration and reduce the amount of time spent in traveling between institutions in different parts of the Bay Area. WebEx software has been used to allow multicast audio.
1c. Teleconferences Telephone conferences have been held twice a month on average (see KEY RESEARCH ACCOMPLISHMENTS).
Milestones:
Focus Groups (FG) have continued to be conducted at major national and international conferences.
• Task 2: Develop clinical database search strategy Developing a clinical database search strategy was accomplished in Year One of the grant. For Year Two of the grant, the focus groups recommended review of individual charts of patients to compare their medications at the time of initiation of rehabilitation and at the time of discharge from acute rehabilitation. These trends in medication use and discontinuation will be provided to the animal model group in an effort to model clinical practice from the bedside to bench.
Task 3: Query Dual Diagnosis clinical database
Having reviewed the databases available locally and nationally for SCI and TBI, the Investigators obtained data from the SCI and the TBI Systems of Care at SCVMC, and the SCI Service and the Polytrauma Center at VAPAHCS.
3a1. SCI and TBI Systems of Care at SCVMC
Patients who had undergone TBI rehabilitation at SCVMC between 1989 and 2010 were identified in the TBI Model Systems (TBIMS) National Database when their Form I (enrollment data) also indicated presence of an SCI.
The admission and discharge notes of 14 patients with combined TBI and SCI diagnosis were then extracted from the hospital records of SCVMC and text mined in detail. The text was parsed into a database that was designed to track the treatment and recovery of the patients throughout the time spent in the brain and spinal rehabilitation facility. Once the database was compiled, an initial comparison utilizing a word cloud analysis of admission and discharge notes was used to provide the first broad visualization of the database.
In this word cloud analysis, the larger a word is in size, the more frequently it appears in the document. In the example below, "fracture" appeared in high frequency. We determined that many of the TBI and SCI patients had undergone multiple fractures at the time of their injury. This was in keeping the expectation that TBI and SCI patients experience multiple co-morbidities or "polytrauma."
Admission notes:
Discharge notes:
The 14 patients with SCI+TBI had a total of 343 unique International Classification of Diseases, Ninth Edition (ICD-9) codes, confirming the variety of comorbidities in this sample. A histogram of the twenty commonest ICD-9 codes for comorbidities is shown below. , 4, 7, 8, 9, 10, 11, 12, 13, 14 NEUROGENIC BLADDER NOS 596.54 1, 4, 7, 8, 9, 11, 12, 13, 14 URINARY TRACT INF NOS 599 1, 4, 7, 8, 9, 10, 12, 13 ICD-9 codes commonly associated with TBI and SCI respectively were extracted from the hospital records and are shown in the two charts below.
Patients were coded with a variety of ICD-9 codes, and individual patients were often coded with more than one ICD-9 code for their SCI and also for their TBI. Note that only 13 out of 14 patients had an ICD-9 code that referenced a traumatic brain injury, and only 11 out of 14 patients had an ICD-9 code that referenced a spinal cord injury.
This indicates that using ICD-9 codes to search hospital records for patients with TBI, SCI, and both TBI and SCI is not a sufficient search strategy to identify all such patients. The search strategy actually used to identify these patients identified individuals who would have not have been found merely by searching for appropriate ICD-9 codes. We extracted demographic data of the TBI and SCI patients in the database to provide a targeted analysis that would provide essential information for further hypothesis testing. The analysis below includes age, gender, etiology of injury, number of days until admission into rehab, length of stay in rehabilitation, and Glasgow Coma Scale (GCS). In addition, the database includes data on injury specifics, surgical procedures, diagnostic findings, physical and neurological exam findings, and rehabilitation assessment plans. In addition, we obtained de-identified Functional Independence Measure (FIM) scores that tracked the functional recovery of the TBI and SCI patients during their stay in rehabilitation. FIM graphs were plotted against the number of weeks spent in rehabilitation. We were able to visualize the functional recovery of each patient throughout rehabilitation. For example, the analysis below shows a single patient with a dual TBI and SCI.
Key: Admit (baseline score recorded at time of admission), Present (raw score recorded during rehabilitation sessions), Short-term goal (decided during weekly conference), Discharge goal (score that is the target for discharge). Finally, descriptive statistics were performed on the FIM and detailed recovery summaries were obtained.
In summary, the second year succeeded in building a clinical TBI and SCI patient database from the Santa Clara Valley Medical Center models system database that details the acute as well as the chronic stage of recovery. During the third year, we plan to increase the number of patients in the TBI + SCI cohort and develop more detailed analysis of the database.
3a2. SCI Service and the Polytrauma Center at VAPAHCS
The strategy used with the Santa Clara Valley records was initially used as a model for extracting data on patients with TBI and SCI in the VA Palo Alto Health Care System, but the considerable differences between these two health care systems necessitated different approaches. The Polytrauma Service at VAPAHCS was founded in 2005, unlike the Model TBI System which has been in operation since 1989. As a result, a search of patients admitted for TBI rehabilitation only identified three patients who also had SCI. The records of patients recently admitted to the VA SCI Service for rehabilitation after acute SCI were therefore searched to identify those with TBI. The full text of all notes on these patients were searched for phrases such as "TBI" and "GCS," and the context of these phrases was examined to determine the way they were used (for example, excluding patients in which the notes recorded that "TBI was ruled out").
This search strategy showed that of an initial cohort of the 45 patients most recently admitted to the SCI Service for rehabilitation after acute SCI, ten (22%) had a TBI. As with SCVMC, we found that ICD-9 codes did not provide a reliable search strategy for identifying SCI and TBI patients.
To provide an initial overview of medications we produced a medication cloud that tracked duration of all medications prescribed during admission for acute rehabilitation. A medication cloud is shown for both a SCI patient and a TBI + SCI 55.9 39.7 *Statistically significant difference (T--test, p <.05)
Length of Stay in Rehabilitation
Neuroscience meeting in New Orleans (October, 2012) . Patients with complete SCI were more likely to have a lower ASIA score than those with incomplete SCI. The level of injury was predominantly cervical, although a little over a third had thoracic, lumbar or multiple level injuries. Since patients treated at the acute neurotrauma center at SFGH are discharged to rehabilitation centers (including the SCVMC and, rarely, the VAPAHCS, rehabilitation measures are not easily available for this cohort, although we have excellent early data for them. One of the goals is to provide better early care data from the VA and SCVMC cohorts, and better long-term outcome data for the SFGH cohorts. We are currently working on identifying the drugs used in this cohort. We will use these data to plan for prospective studies with follow-up to link what we have learned from this early analysis.
3b. Comparison of SCVMC, VAPAHCS, and SFGH/UCSF
A patient's rehabilitation outcome is greatly influenced by the amount of time that passes before they are admitted for rehabilitation. We determined the number of days between the date of injury and the date of admission into rehabilitation, and also the length of stay in rehabilitation, and compared these between SCVMC and the VAPAHCS hospitals. The analysis is shown below: Note that the length of stay in rehabilitation is shorter in SCVMC, a civilian hospital, than VAPAHCS, a VA hospital.
The medications provided to Dual Diagnosis patients were compared between these two hospitals. The most common medications prescribed for these patients on admission to rehabilitation at each hospital are shown below:
Note that the most common medications were those prescribed for management of the neurogenic bowel (e.g docusate, senna, bisacodyl), together with mild analgesics, antacids and bronchodilators.
We compared this with the medications prescribed at the time of discharge from rehabilitation. The most common medications prescribed on discharge are shown below: Note that some bowel medications (docusate and senna) are still among the most commonly prescribed, together with mild analgesics and antacids, but albuterol and low molecular weight heparin have been discontinued and the use of baclofen has increased. The most common medications with potential effects on the central nervous system at the time of admission are shown below.
In the third year of the grant, pilot testing with some of these medications in the combined injury animal model will be undertaken. We will assess gabapentin and baclofen as two of our first drug targets. In addition, we plan to expand the clinical database to allow more detailed comparison of the SCVMC database with the VAPAHCS database so that both can be mined for hypotheses and refined through our community of practice and research.
Specific Aim 2: Develop baseline incomplete SCI plus mild-complicated and moderate TBI rat protocols and outcomes
We have developed an experimental animal model for combined SCI and TBI to help drive mechanistic studies of dual diagnosis. Rats received a unilateral SCI (75 kdyn) at C5 vertebral level, a unilateral TBI (2.0 mm depth, 4.0 m/s velocity impact on the forelimb sensori-motor cortex), or both SCI + TBI. TBI was placed either contralateral or ipsilateral to the SCI. Behavioral recovery was examined using paw placement in a cylinder, grooming, open field locomotion, and the IBB cereal eating test. Over 6 weeks, in the paw placement test, SCI + contralateral TBI produced a profound deficit that failed to recover, but SCI + ipsilateral TBI dramatically enhanced use of the paw on the SCI side. In the grooming test, SCI + contralateral TBI produced worse recovery than either lesion alone even though contralateral TBI alone produced no observable deficit. In the IBB forelimb test, SCI + contralateral TBI revealed a severe deficit that recovered For open field locomotion, SCI alone or in combination with TBI resulted in an initial deficit that recovered in 2 weeks. Thus, TBI and SCI affected forelimb function differently depending upon the test, reflecting different neural substrates underlying, for example, exploratory paw placement and stereotyped grooming. Concurrent SCI and TBI had radically different effects on outcomes and recovery, depending upon laterality of the two lesions. Recovery of function after cervical SCI was retarded by the addition of a moderate TBI in the contralateral hemisphere, but recovery was markedly enhanced by an ipsilateral TBI. These findings emphasize the complexity of recovery from combined CNS injuries, and the possible role of plasticity and laterality in rehabilitation, and provide a start towards a useful preclinical model for evaluating effective therapies for combine SCI and TBI. This work was performed at SFGH.
Specific Aim 3: Test clinic-driven hypotheses for improving outcomes in the dual diagnosis animal model
Based on the interesting data collected in the experimental model of combined injury showing interactive effects of the SCI and TBI, and the clinical data on drugs used, we are currently working on the experimental design for evaluating effects of gabapentin (used for pain management), baclofen (used for spasticity control), and topiramate (used for controlling seizures). These common treatment targets were all identified in the dualdiagnosis patient populations. Although topiramate has been shown to promote recovery from SCI when delivered in the acute phase (Gensel et al, 2012) , it is not known how this treatment given chronically will affect recovery. We hypothesize that this agent will retard recovery if administered chronically, both after SCI and TBI alone, as well as in combined SCI + contralateral TBI. Baclofen has been shown to inhibit recovery after SCI (McDonald et al, 2009 ), and we hypothesize that the effects will be similar on combined injuries (SCI + TBI contralateral or ipsilateral), as the spinal cord effect will be dominant. Gabapentin may affect cognitive processes after spinal cord injury (McKenna et al, personal communication) , and we therefore hypothesize that it will inhibit recovery after combined injury. These studies are being initiated at this time (Oct 2012).
Specific Aim 4: Combine information from clinical practice queries and animal model results to plan for dual diagnosis guidelines
Tasks for Year 3. • Accomplished July, 2012 (at UCSF); We have discovered that the interactive effects of SCI+TBI are more complex than we had expected. We have found that cortical lesions can both enhance deficits induced by SCI, but can also facilitate recovery (depending on lesion placement), possibly by disinhibiting suppressive spinal systems affected by the spinal cord injury. Publication of these findings is pending.
KEY RESEARCH ACCOMPLISHMENTS

Specific Aim 3: Test clinic-driven hypotheses for improving outcomes in the dual diagnosis animal model
• In process; we are currently working on design and implementation of testing in the dual injury animal model, the effects of gabapentin (used for pain management), baclofen (used for spasticity control), and topiramate (used for controlling seizures), all identified as common treatment targets in the dualdiagnosis patient populations.
Specific Aim 4: Combine information from clinical practice queries and animal model results to plan for dual diagnosis guidelines
• Tasks for Year 3
